1. Academic Validation
  2. Natural product inspired scaffold hopping strategy: Identification of potent anticancer 2-arylpyridopyrimidinones that induce cytoplasmic and mitochondrial ROS and G2/M arrest

Natural product inspired scaffold hopping strategy: Identification of potent anticancer 2-arylpyridopyrimidinones that induce cytoplasmic and mitochondrial ROS and G2/M arrest

  • Bioorg Chem. 2026 May:172:109595. doi: 10.1016/j.bioorg.2026.109595.
Gulshan Kumar 1 Satyajit Haldar 2 Ayan Acharya 3 Chirantan Majumder 4 Kuladip Jana 5 Sankar K Guchhait 6
Affiliations

Affiliations

  • 1 Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, SAS Nagar, Mohali, Punjab 160062, India; Amity Institute of Pharmacy, Amity University Haryana, 122413, India.
  • 2 Department of Biological Sciences (Formerly Division of Molecular Medicine), Bose Institute, EN 80, Sector V, Salt Lake City, Kolkata 700091, India; Department of Physiology, Jhargram Raj College, Jhargram College Rd, Jhargram, West Bengal 721507, India.
  • 3 Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, SAS Nagar, Mohali, Punjab 160062, India.
  • 4 Department of Biological Sciences (Formerly Division of Molecular Medicine), Bose Institute, EN 80, Sector V, Salt Lake City, Kolkata 700091, India.
  • 5 Department of Biological Sciences (Formerly Division of Molecular Medicine), Bose Institute, EN 80, Sector V, Salt Lake City, Kolkata 700091, India. Electronic address: kuladip@jcbose.ac.in.
  • 6 Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, SAS Nagar, Mohali, Punjab 160062, India. Electronic address: skguchhait@niper.ac.in.
Abstract

Harnessing the structural complexity and bioactivity of natural products is a proven strategy for discovering novel therapeutics. Here, we report a natural product-inspired structural elaboration of 2-aryl pyridopyrimidinones with C3 installation of drug-privileged motifs. Molecularly diverse analogues were synthesized by an approach of construction of pyridopyrimidinone skeleton, a Pd-catalyzed heterocyclic ring imine-ether CO bond activation-arylation reaction followed by Ullmann-type or Buchwald-Hartwig coupling reactions of CN, CP, CO, and CS bond formations, which enabled an efficient access to flavonoid-inspired molecules with various substitution/functional motifs. These analogs exhibited potent Anticancer activity against multiple carcinoma cell lines. The representative most potent compound 3 s showed significant cytotoxicity against highly aggressive triple-negative breast adenocarcinoma (MDA-MB-231, IC₅₀ = 1.16 ± 0.36 μM), minimal toxicity toward normal kidney epithelial cells (HEK 293) and remarkable selectivity (SI = 72). Wound closure and transwell assays indicated that compound 3s was found to suppress cell migration in a concentration-dependent fashion. Functional mechanistic studies with various biophysical experiments revealed the compound's pronounced effect in Apoptosis induction and biological function interference, such as Bax upregulation, Caspase-3/PARP cleavage, and Akt suppression, mitochondrial membrane potential disruption, accumulation of cytoplasmic and mitochondrial ROS, which led to sub-G0 accumulation and G2/M phase cell cycle arrest. Structure-activity and cheminformatics analyses provides identification of potential key pharmacophoric features and favorable natural product- and drug-likeness profiles.

Keywords

Anticancer activity; Drug-likeness; Drug-privileged motif; Molecular diversity feasible synthesis; NP-likeness; Natural product; Scaffold hopping; Structural elaboration.

Figures
Products